Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28292872 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL28084395 | 0.94 | — | — | |
| SCHEMBL19053 | 0.93 | — | — | |
| Bromide SCHEMBL10644201 | 0.86 | — | — | |
| Methane SCHEMBL4551206 | 0.86 | — | — | |
| Water SCHEMBL5626996 | 0.86 | TSHR (0.50) | — | |
| Water SCHEMBL7675567 | 0.86 | TSHR (0.50) | — | |
| Water SCHEMBL116947 | 0.86 | — | — | |
| SCHEMBL22440692 | 0.86 | — | — | |
| Hydrogen Peroxide SCHEMBL4288872 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 194 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115961138-B | Regenerated magnetic powder, method for preparing regenerated magnetic powder by chloridizing-reducing diffusion combination method and application thereof | 中国科学院江西稀土研究院 | 2023-07-25 | — | — | CN | claimed |
| US-20230135239-A1 | DRUG FOR TREATING SEVERE ACUTE RESPIRATORY SYNDROME CAUSED BY CORONAVIRUS AND COMPLICATIONS THEREOF AND USE OF THE DRUG | SHANGHAI PUBLIC HEALTH CLINICAL CENTER (CN) | 2023-05-04 | — | — | US | claimed |
| CN-115961138-A | Regenerated magnetic powder, method for preparing regenerated magnetic powder by chlorination-reduction diffusion combined method and application thereof | 中国科学院江西稀土研究院 | 2023-04-14 | — | — | CN | claimed |
| CN-115072774-A | Tetragonal phase layered nitride and low-cost high-efficiency preparation method thereof | 桂林理工大学 | 2022-09-20 | — | — | CN | claimed |
| CN-112007158-A | Medicine for treating SARS and its complication caused by coronavirus and its application | 上海市公共卫生临床中心 | 2020-12-01 | — | — | CN | claimed |
| CN-106967712-A | Faeces DNA rapid extraction kit | 广州和实生物技术有限公司 | 2017-07-21 | — | — | CN | claimed |
| CN-105886596-A | Cervical cancer cell detection kit | 南京师范大学 | 2016-08-24 | — | — | CN | claimed |
| CN-101659998-B | Kit for detecting soybean transgene components in soy and use method thereof | UNIV SUN YAT SEN | 2012-01-11 | — | — | CN | claimed |
| CN-101659998-A | Kit for detecting soybean transgene components in soy and use method thereof | UNIV SUN YAT SEN | 2010-03-03 | — | — | CN | claimed |
| CN-1537342-A | Method and product for impriving performance of batteries/fuel cells | ˹ͼ������Դϵͳ��˾ | 2004-10-13 | — | — | CN | claimed |
| EP-0034126-B1 | COSMETIC AND DERMATOLOGICAL COMPOSITIONS FOR SHAVING THE SKIN | Maggesi, Luigi (IT) | 1984-07-04 | — | — | EP | claimed |
| JP-10152422-A | — | — | None | — | — | JP | disclosed |
| US-12279614-B2 | Photo-polymerizable, universal antimicrobial coating to produce high-performing, multi-functional face masks | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 2025-04-22 | — | — | US | disclosed |
| WO-2024131942-A1 | CYCLOPROPANE TLR7 AND TLR8 INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF | 上海深势唯思科技有限责任公司 | 2024-06-27 | — | — | WO | disclosed |
| CN-118239959-A | Cyclopropane TLR7 and 8 inhibitor and preparation method and application thereof | 上海深势唯思科技有限责任公司 | 2024-06-25 | — | — | CN | disclosed |
| EP-0413293-A2 | 1-(Benzo[b]thienyl)-2-(thienyl) ethenes and related compounds, a process for their preparation and their use as medicaments | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1991-02-20 | — | — | EP | disclosed |
| US-4904674-A | FREE OF AGGLOMERATION OF FIBRILLATION | HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) | 1990-02-27 | — | — | US | disclosed |
| EP-0225778-A1 | Improved synthesis and purification of alpha-d-propoxyphene hydrochloride | Mallinckrodt, Inc. (a Delaware corporation) (US) | 1987-06-16 | — | — | EP | disclosed |
| US-4661625-A | Synthesis and purification of d-propoxyphene hydrochloride | MALLINCKKODT, INC. (US) | 1987-04-28 | — | — | US | disclosed |
| US-4548950-A | GLYCYRRHETINIC ACID DERIVATIVE AND SALT AS STABILIZER | BIOREX LABORATORIES LIMITED (GB) | 1985-10-22 | — | — | US | disclosed |